Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06436690 · ClinicalTrials.gov registry record · NA
Optimizing Antibiotics Prescription
A NA study of Antimicrobial Resistance, sponsored by Penn State University.
- Active
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 2
- Study locations
NCT06436690: Active NA study of Antimicrobial Resistance, sponsored by Penn State University.
NCT06436690 is a NA study of Antimicrobial Resistance that is active but no longer recruiting, run by Penn State University. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06436690, a NA study of Antimicrobial Resistance, is active but no longer recruiting, sponsored by Penn State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 2
- Study locations
Study Summary
Interventions that are low-cost, do not add substantially to the physician workload, are consistent with good physician practices and WHO guidelines, and serve as a reminder on the risks of overprescribing antibiotics are critically needed. The overall goal of the proposed project is to test the effect of two behavioral interventions targeted to junior physicians-specifically, requiring them to specify the diagnosis in the prescription note and providing feedback-on their antibiotics prescription rate; examine the intervention's effects across gender and caste; and draw lessons for scaling up the intervention.
Primary Outcome
The number of patient visits in which antibiotics are prescribed by the total number of visits
Conditions Studied
Interventions
- BEHAVIORAL Individualized Feedback
- BEHAVIORAL Diagnosis Mandate
Study Locations (2)
Pennsylvania
- Pennsylvania State University - University Park
Bagmati
- Institute for Social and Environmental Research - Nepal - Bharatpur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT06436690 still lists
NCT06436690 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Antimicrobial Resistance appearing as the primary indexed condition, and to 2 interventions - of which Individualized Feedback is the first listed.
NCT06436690 reports a single indexed study location in Pennsylvania, Bagmati.
Frequently Asked Questions
What is clinical trial NCT06436690 about?
NCT06436690 is a clinical study titled "Optimizing Antibiotics Prescription". Interventions that are low-cost, do not add substantially to the physician workload, are consistent with good physician practices and WHO guidelines, and serve as a reminder on the risks of overprescribing antibiotics are critically needed. The overall goal of the proposed project is to test the eff...
What is the current status of trial NCT06436690?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2025-04-15. Estimated completion is 2026-04-30.
What conditions does trial NCT06436690 study?
This clinical trial studies the following conditions: Antimicrobial Resistance.
What interventions are being tested in trial NCT06436690?
The interventions under investigation include: Individualized Feedback (BEHAVIORAL), Diagnosis Mandate (BEHAVIORAL).
Who is sponsoring clinical trial NCT06436690?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06436690 being conducted?
This trial has 2 study locations across Pennsylvania, Bagmati. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Antimicrobial Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06436690's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI